The potential value of partnership deals signed in Q307 hit ∼$10 billion, triple the total in Q207 and double that in Q306. A few deals in the $500-million-plus range helped to drive these numbers. Stocks were also buoyant at the end of the third quarter. Venture capital (VC) investment in the area remains relatively constant. Market volatility, however, sank the initial public offering (IPO) market, which saw only a few issues.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lawrence, S. Partnering up in Q3. Nat Biotechnol 25, 1200 (2007). https://doi.org/10.1038/nbt1107-1200
Issue Date:
DOI: https://doi.org/10.1038/nbt1107-1200
